About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 1944 blog entries.

North Carolina

The Board’s revised centralized pharmacy services rule has cleared final review. The chief change achieved by the amendments is to broaden the availability of remote medication order processing from the health-system practice setting to all pharmacy practice settings.  

Even though the amended rule is effective March 1, 2022, several implementation tasks need to be completed. Chief among them: Board staff need to program a registration system for out-of-state pharmacists who are not licensed in North Carolina, but who intend to provide RMOE services to North Carolina pharmacies by obtaining an NABP (National Association of Boards of Pharmacy) Verify credential. NABP staff are implementing the NABP Verify credential application process. Board staff expect both steps to be completed by April 1, 2022.  

In the meantime, North Carolina pharmacies who have implemented RMOE systems under the Board’s emergency services waiver may continue to use them. The Board will ensure that pharmacies that have deployed waiver-based RMOE operations have reasonable time and opportunity to transfer to rule-based operations. The full Board will discuss implementation at its March 8, 2022, meeting.  

In the coming weeks, Board staff will also publish a detailed FAQ document on the revised centralized pharmacy services rule. 

Pharmacists are reminded that the Board is proceeding with additional rulemaking to permanently authorize North Carolina pharmacy personnel to perform remote work (other than physical acts in the dispensing process) for their employing pharmacy. North Carolina pharmacies who have implemented waiver-based remote work systems in North Carolina may continue to use them while this rulemaking proceeds. More information on this proposed rule is found here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-02-25T11:36:05-05:00February 25, 2022|North Carolina|

Ohio

HB 37, a bill that NACDS and the Ohio Council of Retail Merchants jointly supported, has passed both Chambers and is on its way to the Governor for signature. Sponsored by Rep. Gayle Manning (R), it authorizes pharmacists to dispense emergency refills three times a year and requires health insurers to cover these prescriptions.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-02-25T11:35:05-05:00February 25, 2022|Ohio|

Oklahoma

The Pharmacy Board will be moving to a temporary location while the office building is being renovated. The office will be down during the move, from February 28 the to March 4th. The new address is 3812 N. Santa Fe Suite 300, Oklahoma City, OK 73118. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-25T11:34:29-05:00February 25, 2022|Oklahoma|

Oregon

The Board of Pharmacy proposed to adopt the following rules. Written comments may be submitted via email to pharmacy.rulemaking@bop.oregon.gov before 4:30 p.m. on March 29 rulemaking hearing. 

Also in Oregon, the Department of Human Services announced plans to lift mask requirements for indoor public spaces and schools on March 19. 

Finally in Oregon, Gov. Kate Brown (D) announced that she will lift the state’s COVID-19 Emergency Declaration effective April 1. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-02-25T11:33:37-05:00February 25, 2022|Oregon|

Pennsylvania

The Department of Human Services released a new bulletin announcing SARS-CoV-2 Monoclonal Antibody Product Updates that includes pharmacy reimbursement rates and billing procedures.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-02-25T11:30:19-05:00February 25, 2022|Pennsylvania|

Texas

The Health and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) is accepting comments until March 10th on the March 2022 draft Specialty Drug List. Stakeholders should send submissions on the Specialty Drug Submission Spreadsheet. 

 Also in Texas, the HHSC adopted a final rule establishing a process for Medicaid Managed Care organizations (MCOs) to recoup certain overpayments made to health care providers in connection with missing electronic visit verification information. The rule also requires MCOs to give providers at least 60 days to correct a deficiency.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-25T11:27:54-05:00February 25, 2022|Texas|

Utah

The Board of Pharmacy published its February 2022 newsletter. Highlights include the impact of HB 178 on pharmacy practice, pharmacy staff supervision, insulin refills, Controlled Substance Database (CDS) updates when returning controlled substances to stock, CDS and the DSP12 Transmission Form of Rx Origin Code and SafeUT Frontline app.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-02-25T11:25:07-05:00February 25, 2022|Utah|

Virginia

The Legislature’s crossover deadline for bills to pass one chamber to be eligible for further consideration was met on February 15. The following bills of interest to pharmacy met the deadline: 

  • HB 1323 and SB 672 – both bills expand pharmacy personnel immunization and testing authority to mirror the PREP (Public Readiness and Emergency Preparedness) Act; SB 672 also expands the state’s current allowances on conditions pharmacists may test and/or treat. NACDS has been actively supporting both bills, which are headed for consideration in conference committee 
  • HB 1324 – this bill requires the Board of Pharmacy to adopt regulations for work environment requirements for pharmacy personnel by September 1, 2022. The regulations must include addressing pharmacy staffing and breaks; state standards that ensure adequate time to complete professional duties; and limit productivity or production quotas to the extent that such factors interfere with the ability to provide appropriate professional services to the public. The bill was amended to remove language that would have allowed it to be promulgated as an emergency measure, thus ensuring stakeholders’ ability to participate in the regulatory process 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-02-25T11:24:32-05:00February 25, 2022|Virginia|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top